Cytokine profile of patients with chronic immune thrombocytopenia affects platelet count recovery after Helicobacter pylori eradication

British Journal of Haematology

Volumn 168, Issue 3, 2015, Pages 421-428

  Rocha, Andreia M C ^a   Souza, Cláudia ^a   Melo, Fabrício F ^a   Clementino, Nelma C D ^a   Marino, Marília C A ^a   Rocha, Gifone A ^a   Queiroz, Dulciene M M ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

Chronic immune thrombocytopenia; Cytokine; Helicobacter pylori

Indexed keywords

BISMUTH CITRATE; CLARITHROMYCIN; FURAZOLIDONE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12P70; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 23P19; INTERLEUKIN 4; INTERLEUKIN 6; LANSOPRAZOLE; OXYTETRACYCLINE; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1; ANTIINFECTIVE AGENT; CYTOKINE; TGFB1 PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; BACTERIAL CLEARANCE; BLOOD SAMPLING; CHRONIC IMMUNE THROMBOCYTOPENIA; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE DURATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HELPER CELL; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; REGULATORY T LYMPHOCYTE; REMISSION; TH1 CELL; TH17 CELL; TH2 CELL; THROMBOCYTE COUNT; THROMBOCYTOPENIA; UREA BREATH TEST; VERY ELDERLY; ADOLESCENT; BLOOD; CLINICAL TRIAL; COMPLICATION; DRUG COMBINATION; HELICOBACTER INFECTIONS; IDIOPATHIC THROMBOCYTOPENIC PURPURA; IMMUNOLOGY; LYMPHOCYTE COUNT; MICROBIOLOGY; MIDDLE AGED; PROSPECTIVE STUDY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; CYTOKINES; DRUG THERAPY, COMBINATION; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; LYMPHOCYTE COUNT; MALE; MIDDLE AGED; PLATELET COUNT; PROSPECTIVE STUDIES; PURPURA, THROMBOCYTOPENIC, IDIOPATHIC; REMISSION INDUCTION; T-LYMPHOCYTES, REGULATORY; TH1 CELLS; TH17 CELLS; TRANSFORMING GROWTH FACTOR BETA1; YOUNG ADULT;

EID: 84921328459     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/bjh.13141     Document Type: Article

References (35)

1. Andersson, P.O., Stockerlberg, D., Jacobsson, S. & Wadenvik, H. (2000) A transforming growth factor-beta1-mediated bystander immune suppression could be associated with remission of chronic idiopathic thrombocytopenic purpura. Annals of Hematology, 79, 507-513.
2. Arnold, D.M., Bernotas, A., Nazi, I., Stasi, R., Kuwana, M., Liu, Y., Kelton, J.G. & Crowther, M.A. (2009) Platelet count response to H. pylori treatment in patients with immune thrombocytopenic purpura with and without H. pylori infection: a systematic review. Haematologica, 94, 850-856.
3. Campuzano-Maya, G. (2007) Proof of an association between Helicobacter pylori and idiopathic thrombocytopenic purpura in Latin America. Helicobacter, 12, 265-273.
4. Emilia, G., Luppi, M., Zucchini, P., Morselli, M., Potenza, L., Forghieri, F., Volzone, F., Jovic, G., Leonardi, G., Donelli, A. & Torelli, G. (2007) Helicobacter pylori infection and chronic immune thrombocytopenic purpura: long-term results of bacterium eradication and association with bacterium virulence profiles. Blood, 110, 3833-3841.
5. Franceschi, F., Christodoulides, N., Kroll, M.H. & Genta, R.M. (2004) Helicobacter pylori and idiopathic thrombocytopenic purpura. Annals of Internal Medicine, 140, 766-767.
6. Guo, C., Chu, X., Shi, Y., He, W., Li, L., Wang, L., Peng, J. & Hou, M. (2007) Correction of Th1-dominat cytokine profiles by high-dose dexamethasone in patients with chronic idiopathic thrombocytopenic purpura. Journal of Clinical Immunology, 27, 557-562.
7. Inaba, T., Mizuno, M., Take, S., Suwaki, K., Honda, T., Hawai, K., Fujita, M., Tamura, T., Yokota, K., Oguma, K., Okada, H. & Shiratori, Y. (2005) Eradication of Helicobacter pylori increases platelet count in patients with idiopathic thrombocytopenic purpura in Japan. European Journal of Clinical Investigation, 35, 214-219.
8. Jarque, I., Andreu, R., Llopis, I., De la Rubia, J., Gomis, F., Senet, L., Jiménez, C., Martín, G., Martínez, J.A., Sanz, G.F., Ponce, J. & Sanz, M.A. (2001) Absence of platelet response after eradication of Helicobacter pylori infection in patients with chronic idiopathic thrombocytopenic purpura. British Journal of Haematology, 115, 1002-1003.
9. Ji, L., Zhan, Y., Hua, F., Li, F., Zou, S., Wang, W., Song, D., Min, Z., Chen, H. & Cheng, Y. (2012) The ratio of Treg/Th17 cells correlates with the disease activity of primary immune thrombocytopenia. PLoS one, 7, e50909.
10. Kohda, K., Kuga, T., Kogawa, K., Kanisawa, Y., Koike, K., Kuroiwa, G., Hirayama, Y., Sato, Y., Matsunaga, T. & Niitsu, Y. (2002) Effect of H. pylori eradication on platelet recovery in Japanese patients with chronic idiopathic thrombocytopenic purpura and secondary autoimmune thrombocytopenic purpura. British Journal of Haematology, 118, 584-588.
11. McMillan, R. (2009) Antiplatelet antibodies in chronic Immune Thrombocytopenia and their role in platelet destruction and defective platelet production. Hematology/oncology Clinics of North America, 23, 1163-1175.
12. Melo, F.F., Rocha, A.M.C., Pedroso, S.H.S.P., Batista, S.A., Castro, L.P.F., Carvalho, S.D., Bittencourt, P.F.S., Oliveira, C.A., Corrêa-Oliveira, R. & Queiroz, D.M.M. (2012) A regulatory instead of an IL-17 T response predominates in Helicobacter pylori-associated gastritis in children. Microbes and Infection, 14, 341-347.
13. Melo, F.F., Rocha, G.A., Rocha, A.M.C., Teixeira, K.N., Pedroso, S.H.S.P., Pereira-Jr, J.B., Castro, L.P.F., Cabral, M.M.D.A., Carvalho, S.D., Bittencourt, P.F.S., Oliveira, C.A. & Queiroz, D.M.M. (2014) Th1 immune response to H. pylori infection varies according to the age of the patients and influences the gastric inflammatory patterns. International Journal of Medical Microbiology, 304, 300-306.
14. Michel, M., Cooper, N., Jean, C., Frissora, C. & Bussel, J.B. (2004) Does Helicobacter pylori initiate or perpetuate immune thrombocytopenic purpura? Blood, 103, 890-896.
15. Mouzaki, A., Theodoropoulou, M., Gianakopoulos, I., Vlaha, V., Kyrtsonis, M.C. & Maniatis, A. (2002) Expression patterns of Th1 and Th2 cytokines genes in childhood idiopathic thrombocytopenic purpura (ITP) at presentation and their modulation by intravenous immunoglobulin G (IVIg) treatment: their role in prognosis. Blood, 100, 1774-1779.
16. Olsson, B., Andresson, P.O., Jernas, M., Jacobsson, S., Carlsson, B., Carlsson, L.M.S. & Wadenvik, H. (2003) T-cell mediated cytotoxicity toward platelets in chronic idiopatic thrombocytopenic purpura. Nature Medicine, 9, 1123-1124.
17. Panitsas, F.P., Theodoropoulou, M., Kouraklis, A., Theodorou, G.L., Zoumbos, N.C., Maniatis, A. & Mouzaki, A. (2004) Adult chronic idiopathic thrombocytopenic purpura is the manifestation of a type-1 polarized immune.response. Blood, 103, 2645-2647.
18. Provan, D., Stasi, R., Newland, A.C., Blanchette, V.S., Bolton-Maggs, P., Bussel, J.B., Chong, B.H., Cines, D.B., Gernsheimer, T.B., Godeau, B., Graiger, J., Greer, I., Hunt, B.J., Imbach, P.A., Lyons, G., McMillan, R., Rodeghiero, F., Sanz, M.A., Tarantino, M., Watson, S., Young, J. & Kuter, D.J. (2010) International consensus report on the investigation and management of primary immune thrombocytopenia. Blood, 115, 168-186.
19. Queiroz, D.M.M., Guerra, J.B., Rocha, G.A., Rocha, A.M.C., Santos, A., Oliveira, A.G., Cabral, M.M.D.A., Nogueira, A.M.M.F. & Oliveira, C.A. (2004) IL1B and IL1RN polymorphic genes and Helicobacter pylori cagA strains decrease the risk of reflux esophagitis. Gastroenterology, 127, 73-79.
20. Rocha, A.M.C., Souza, C., Rocha, G.A., Melo, F.F., Clementino, N.C.D., Marino, M.C.A., Bozzi, A., Silva, M.L., Martins-Filho, O.A. & Queiroz, D.M.M. (2011) The levels of IL-17A and of the cytokines involved in Th17 cell commitment are increased in patients with chronic immune thrombocytopenia. Haematologica, 96, 1560-1564.
21. Rodeghiero, F., Stasi, R., Gernsheimes, T., Michel, M., Provan, D., Arnold, D.M., Bussel, J.B., Cinews, D.B., Chong, B.H., Cooper, N., Godeau, B., Lechneer, K., Mazzucconi, M.G., McMillan, R., Sanz, M.A., Imbach, P., Blancette, V., Kuhne, T., Ruggeri, M. & George, J.N. (2009) Standardization of terminology, definition and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group. Blood, 113, 2386-2393.
22. Rostami, N., Keshtkar-Jahromi, M., Rahnavardi, M., Keshtkar-Jahromi, M. & Esfahani, F.S. (2008) Effect of eradication of Helicobacter pylori on platelet recovery in patients with chronic thrombocytopenic purpura: a controlled trial. American Journal of Hematology, 83, 376-381.
23. Semple, J.W. & Freedman, J. (1991) Increased antiplatelet T helper lymphocyte reactivity in patients with autoimmune thrombocytopenia. Blood, 78, 2619-2625.
24. Semple, J.W., Milev, Y., Cosgrave, D., Mody, M., Hornstein, A., Blanchette, V. & Freedman, J. (1996) Differences in serum cytokine levels in acute and chronic Autoimmune Thrombocytopenic Purpura: relationship to platelet phenotype and antiplatelet T cell-reactivity. Blood, 87, 4245-4254.
25. Stasi, R., Rossi, Z., Stipa, E., Amadori, S., Newland, A.C. & Provan, D. (2005) Helicobacter pylori eradication in the management of patients with idiopathic thrombocytopenic purpura. American Journal of Medicine, 118, 414-419.
26. Stasi, R., Evangelista, M.L., Stipa, E., Buccisano, F., Venditti, A. & Amadori, S. (2008a) Idiopathic thrombocytopenic purpura: current concepts in pathophysiology and management. Thrombosis and Haemostasis, 99, 4-13.
27. Stasi, R., Cooper, N., Del Poeta, G., Stipa, E., Evangelista, M.L., Abruzzese, E. & Amadori, S. (2008b) Analysis of regulatory T-cell changes in patients with idiopathic thrombocytopenic purpura receiving B cell-depleting therapy with rituximab. Blood, 112, 1147-1150.
28. Stasi, R., Sarpatwari, A., Segal, J.B., Osborn, J., Evangelista, M.L., Cooper, N., Provan, D., Newland, A., Amadori, S. & Bussel, J.B. (2009) Effects of eradication of Helicobacter pylori infection in patients with immune thrombocytopenic purpura: a systematic review. Blood, 113, 1231-1240.
29. Takahashi, T., Yujiri, T., Shinohara, K., Inoue, Y., Sato, Y., Fujii, Y., Okubo, M., Zaitsu, Y., Ariyoshi, K., Nakamura, Y., Nawata, R., Oka, Y., Shirai, M. & Tanizawa, Y. (2004) Molecular mimicry by Helicobacter pylori CagA protein may be involved in the pathogenesis of H. pylori-associated chronic idiopathic thrombocytopenic purpura. British Journal of Haematology, 124, 91-96.
30. Torres, J., Perez-Perez, G., Goodman, K.J., Atherton, J.C., Gold, B.D., Harris, P.R., La Garza, A.M., Guarner, J. & Muñoz, O. (2000) A comprehensive review of the natural history of Helicobacter pylori infection in children. Archives of Medical Research, 31, 431-469.
31. Veneri, D., Franchini, M., Gottardi, M., Dàdda, M., Ambrosetti, A., Krampera, M., Zanetti, F. & Pizzolo, G. (2002) Efficacy of Helicobacter pylori eradication in raising platelet count in adult patients with idiopathic thrombocytopenic purpura. Haematologica, 87, 1177-1179.
32. + T cells in autoimmunity. Current Opinion in Immunology, 17, 624-631.
33. Zhang, F., Chu, X., Wang, L., Zhu, Y., Li, L., Ma, D., Peng, J. & Hou, M. (2006) Cell-mediated lysis of autologous platelets in chronic idiopathic thrombocytopenic purpura. European Journal of Haematology, 76, 427-431.
34. Zhao, C., Li, X., Zhang, F., Wang, L., Peng, J. & Hou, M. (2008) Increased cytotoxic T-lymphocyte-mediated cytotoxicity predominant in patients with idiopathic thrombocytopenic purpura without platelet autoantibodies. Haematologica, 93, 1428-1430.
35. Zhou, B., Zhao, H., Yang, R.C. & Han, Z.C. (2005) Multi-dysfunctional pathophysiology in ITP. Critical Reviews in Oncology Hematology, 54, 107-116.